Jeff Nagge

Dr. Jeff Nagge is a Clinical Associate Professor at the University of Waterloo School of Pharmacy and Director of the school's Pharmacy Residency Program. His research focuses on integrating artificial intelligence into pharmacy education and optimizing cardiovascular medication therapy through innovative pharmacist-led models. He also operates a specialized pharmacist-managed hypertension clinic at the Centre for Family Medicine, the first of its kind in Canada.

• Integration of artificial intelligence and virtual simulation in healthcare professional education

• Optimization of cardiovascular medication therapy through innovative pharmacist-led models

• Problem-based and experiential learning in pharmacy education

• 2004, PharmD, University of Toronto (Honours)

• 2001, Accredited Canadian Pharmacy Resident (ACPR), Hamilton Health Sciences

• 2000, BScPhm, University of Toronto (Honours)

• 1995, BSc Honours Science (Minor in Chemistry), University of Waterloo

• 2025 Interprofessional Preceptor of the Year, McMaster University Family Medicine

• 2024 Award for Innovation in Education, Association of Faculties of Pharmacy of Canada

• 2023 Silver Medal, Best Use of Generative AI, QS Reimagine Education Awards

• 2022 Excellence in Teaching, McMaster University

• 2019 Winner, Non-credit Programming, Canadian Association for University Continuing Education

• Dr. Nagge was appointed as the founding Director of the University of Waterloo School of Pharmacy’s Ambulatory Care Pharmacy Residency Program in 2016.

• He continues to practice as a clinical consultant at the Centre for Family Medicine Academic Family Health Team in Kitchener, where he has managed a referral-based hypertension clinic since 2007. His earlier contributions include the development of several innovative clinical services such as a point-of-care anticoagulation clinic and arterial and venous thrombosis clinics, all of which were groundbreaking at the time of their inception.

• OPTOM 231 - Introductory Clinical Pharmacology
  • Taught in 2020, 2021
• PHARM 222 - Integrated Patient Focused Care 3
  • Taught in 2020, 2021, 2022, 2023, 2024, 2025
• PHARM 422 - Integrated Patient Focused Care 9
  • Taught in 2020, 2021, 2022, 2024, 2025
• PHARM 467 - Management of Oral Anticoagulation Therapy
  • Taught in 2020, 2021, 2022, 2024, 2025
• PHARM 651 - Advanced Principles of Medication Management 1
  • Taught in 2021

* Only courses taught in the past 5 years are displayed.

• Nagge J, Richard C, Bennett B, Tang F, Clapperton R. AI-enabled virtual clinic impact on pharmacist confidence in managing warfarin: implications for experiential education. Am J Pharm Educ. 2025;89(10):101494.

• Champigny J, Nagge J. Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary care. Canadian Pharmacists Journal 2024;157(6):334-340.

• Morrison L, Nagge J. The quality of community warfarin management across two provinces in Canada: A cross-sectional observational study. Canadian Pharmacists Journal 2024;157(2):77-83.

• Nagge J, Lee-Poy MF, Richard CL. Evaluation of a unique interprofessional education program involving medical and pharmacy students. American Journal of Pharmaceutical Education 2017;81(10):Article 6140.

• Dhalla IA, Gomes T, Yao Z, Nagge J, et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: A population-based cohort study. Annals of Internal Medicine 2013;158(6):447-455.

• Nagge J, Crowther M, Hirsh J. Is renal impairment a contraindication to the use of low molecular weight heparin? Archives of Internal Medicine 2002;162:2605-9.